TFIIIB90-1 (E257) Antibody-抗体-抗体-生物在线
巴傲得生物科技有限公司
TFIIIB90-1 (E257) Antibody

TFIIIB90-1 (E257) Antibody

商家询价

产品名称: TFIIIB90-1 (E257) Antibody

英文名称: TFIIIB90-1 (E257) Antibody

产品编号: BS2567

产品价格: null

产品产地: USA

品牌商标: Bioworld

更新时间: null

使用范围: WB: 1:500~1:1000 IHC: 1:50~1:200 IF: 1:50~1:200

巴傲得生物科技有限公司
  • 联系人 :
  • 地址 : 南京市纬地路9号江苏生命科技园
  • 邮编 : 210036
  • 所在区域 : 上海
  • 电话 : 189****5941 点击查看
  • 传真 : 点击查看
  • 邮箱 : order@biogot.com

RNA polymerase (pol) III synthesizes tRNA, 5s rRNA, 7SL RNA and U6 snRNA and is overexpressed in many transformed cell lines and tumors in vivo, since cells must duplicate its protein components before division. Therefore, in order to maintain rapid growth, cells must produce a high level of Pol III transcribed RNA, which requires the presence of the TFIIIB and TFIIIC2 transcription factor complexes. The TFIIIC2 complex is composed of five subunits, TFIIIC220, TFIIIC110, TFIIIC102, TFIIIC90 and TFIIIC63, that are overexpressed in adenovirus transformed cells as well as in malignant cells in vivo, such as ovarian carcinomas. TFIIIC2 recruits RNA pol III and TFIIIB to promoter elements and may be a key component in the deregulation of malignant cells. The TFIIIB complex includes the TATA-binding protein (TBP), TFIIB-related factor 1 (TFIIIB90, BRF1) and TFIIIB, the expression of which are also upregulated in transformed cells. In many carcinomas, the tumor suppressors retinoblastoma (RB) and p53 are inactivated, which affects their ability to bind and inactivate the function of TFIIIB.